PT-018 - A POLYGENIC DNA DAMAGE REPAIR PHARMACOGENOMICS (DDR_PGX) SCORE PREDICTS RESPONSE TO GEMTUZUMAB OZOGAMICIN IN PEDIATRIC AML PATIENTS.
V. Shastri1, L. Chauhan1, T. Alonzo2, Y. Wang3, R. Aplenc4, B. Hirsch5, A. Gamis6, S. Meshinchi7, J. Lamba1; 1University of Florida, Gainesville, FL, USA, 2University of Southern California, Los Angeles, LA, USA, 3Children's Oncology Group, Monrovia, CA, USA, 4Children's Hospital of Philadelphia, Philadelphia, PA, USA, 5University of Minnesota, Minneapolis, MN, USA, 6Children's Mercy Hospital, Kansas City, MO, USA, 7Fred Hutchinson Cancer Research Center, Seattle, WA, USA.